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Abstract
Recent US work identifies “metabolically healthy overweight” and “metabolically at risk normal
weight” individuals. Less is known for modernizing countries with recent increased obesity.
Fasting blood samples, anthropometry and blood pressure from 8,233 adults aged 18–98 in the
2009 nationwide China Health and Nutrition Survey, were used to determine prevalence of
overweight (Asian cut point, BMI≥23 kg/m2) and five risk factors [pre-diabetes/diabetes
(HbA1c≥5.7%) inflammation (hsCRP ≥3 mg/L), pre-hypertension/hypertension (SBP/
DBP≥130/85 mmHg), high triglycerides (≥150 mg/dL), low high-density lipoprotein cholesterol
(<40 (men)/<50 mg/dL (women)]. Sex-stratified, logistic and multinomial logistic regression
models estimated concurrent obesity and cardiometabolic risk, with and without abdominal
obesity, adjusting for age, smoking, alcohol consumption, physical activity, urbanicity, and
income. Irrespective of urbanicity, 78.3% of the sample had ≥1 elevated cardiometabolic risk
factor (normal weight: 33.2% had ≥1 elevated risk factor; overweight: 5.7% had none). At age 18–
30, 47.4% had no elevated risk factors, which dropped to 6% by age 70, largely due to age-related
increase in hypertension risk (18–30 years: 11%, >70 years: 73%). Abdominal obesity was highly
predictive of metabolic risk, irrespective of overweight (e.g., “metabolically at risk overweight”
relative to “metabolically healthy normal weight” [men: Relative Risk Ratio (RRR) =39.06; 95%
Confidence Interval (CI): 23.47, 65.00; women: RRR=22.26; 95% CI: 17.49, 28.33]). To
conclude, a large proportion of Chinese adults have metabolic abnormalities. High hypertension
risk with age, irrespective of obesity underlies the low prevalence of metabolically healthy
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toverweight. Screening for cardiometabolic-related outcomes dependent upon overweight will
likely miss a large portion of the Chinese at-risk population.
INTRODUCTION
In the US, approximately 16.3 million adults are of normal weight but have two or more
metabolic abnormalities.(1) Understanding heterogeneity in risk by overweight status is
important particularly in the metabolically at risk but non-overweight population as these
individuals often elude screening as they are not perceived as high risk. However, little is
known about heterogeneity in risk in Asian populations, and particularly in China where
rates of obesity-related non-communicable diseases have recently increased and are now the
leading causes of morbidity, disability, and mortality.(2, 3)
Given that Asians are known to have relatively high abdominal obesity(4) and high
prevalence of cardiometabolic risk factors at relatively low BMI(5) and at younger ages,(6)
understanding how abdominal obesity associates with cardiometabolic risk in the absence of
(and in combination with) obesity is important. Although abdominal obesity does not confer
the same level of risk for hypertension, diabetes, inflammation and dyslipidemia, many
studies rely on syndrome-based indicators (e.g., metabolic syndrome(7, 8), Framingham risk
score(9, 10)) and thus may miss important variation that can be observed by investigating
variation in co-occurrence of obesity and cardiometabolic risk across individual risk factors.
Understanding the distribution of cardiometabolic risk by age and across overweight and
non-overweight individuals is essential for determining the impending burden of
cardiovascular disease in China, home to more than 1.3 billion people and comprising one
fifth of the world’s population. The distribution of cardiometabolic risk factors, particularly
among the non-overweight population is particularly important for prevention as these
individuals are likely to be missed in screening efforts. To this end, a national Chinese
cohort was examined to determine the prevalence of “metabolically healthy overweight” and
“metabolically at risk normal weight” by age. Analyses were structured to test the
hypothesis that the association between overweight and five risk factors [pre-diabetes/
diabetes (HbA1c≥5.7%) inflammation (hsCRP ≥3 mg/L), pre-hypertension/hypertension
(SBP/DBP≥130/85 mmHg), high triglycerides (≥150 mg/dL), low high-density lipoprotein
cholesterol (<40 (men)/<50 mg/dL (women)] varies, depending upon the indicator. Further
analyses tested independent and interactive effects of overweight and abdominal obesity
across pre-hypertension or hypertension, pre-diabetes or diabetes, high triglycerides, low
HDL-C, and inflammation.
MATERIALS & METHODS
The China Health and Nutrition Survey (CHNS)
The CHNS collected health data in 228 communities [nine diverse provinces (Guangxi,
Guizhou, Heilongjiang, Henan, Hubei, Hunan, Jiangsu, Liaoning, and Shandong)]
throughout China from 1989–2009 with eight rounds of surveys, with the 2009 survey
collecting fasting blood for the first time. Using multistage, random cluster sampling,
counties in the nine provinces were stratified by income and weighted sampling was used to
randomly select four counties in each province. Villages and small towns within counties
and urban and suburban neighborhoods within cities were selected randomly into primary
sampling units that were politically and geographically classified based on State Statistical
Office definitions. The surveyed provinces represent 56% of the Chinese population. Survey
procedures have been described elsewhere.(11) The study was approved by the Institutional
Review Board at the University of North Carolina at Chapel Hill, the China-Japan
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tFriendship Hospital, Ministry of Health and China, and Institute of Nutrition and Food
Safety, China Centers for Disease Control and subjects gave informed consent for
participation.
Analysis Sample
A total of 10,038 adult respondents were surveyed at the 2009 exam, 1,423 did not give
blood, 24 were not fasting, and 62 were pregnant, resulting in a total of 8,529 individuals
with fasting blood samples. Of these, 237 were missing anthropometry and 60 were missing
lab results, resulting in an analytic sample of 8,233 with anthropometry and clinical exam
data. There were no statistically significant differences in the total 2009 sample versus the
analytic sample in income, urbanization, BMI, cardiometabolic risk or overweight, although
the analytic sample included more women, was slightly younger, and had slightly larger
waist circumference.
Measures
Cardiometabolic Risk—Following an overnight fast, blood was collected by
venipuncture (12-ml). Whole blood was immediately centrifuged and serum glucose testing
completed. The remaining plasma and serum samples were immediately frozen and stored
for later laboratory analysis. All samples were processed in a national central lab in Beijing
(medical laboratory accreditation certificate ISO 15189:2007) using automatic analyzer,
with strict quality control.
Hemoglobin A1c (HbA1c) was measured in whole blood with an automated
glycohemoglobin analyzer by using high-performance liquid chromatography system
(model HLC-723 G7; Tosoh Corporation, Tokyo, Japan). HbA1c is used as a marker of pre-
diabetes or diabetes (values ≥5.7%) according to an International Expert Committee.(12) We
also conducted comparative sensitivity analyses using fasting glucose (Supplemental Tables
2 and 3, Supplemental Figure 1). Plasma triglyceride and HDL-C were measured by using
the glycerol-phosphate oxidase method, the PEG-modified enzyme HDL-C assay by
determiner regents (Kyowa Medex Co., Ltd, Tokyo, Japan) on the Hitachi 7600 automated
analyzer (Hitachi Inc., Tokyo, Japan). The International Diabetes Federation (IDF) criteria
for adults(13) is used for indicators of dyslipidemia risk (high triglycerides: ≥150 mg/dL;
low HDL-C: (male: <40 mg/dL; female<50 mg/dL) or taking lipid lowering medication.
High-sensitivity C-reactive protein (hsCRP), using the immunoturbidimetric method with
Denka Seiken, Japan reagents (Hitachi 7600 automated analyzer, Hitachi Inc., Tokyo,
Japan) is used as a marker of inflammation, with values ≥3 mg/dL indicating high risk.(14)
Elevated hsCRP is a strong independent risk factor for future cardiovascular events,
regardless of the underlying condition.(15)
Systolic (SBP) and diastolic (DBP) blood pressure were measured on the right arm, using
mercury sphygmomanometers with appropriate cuff sizes. Measures were collected in
triplicate after a 10 minute seated rest and the mean of the three measurements used in
analyses. Risk was determined as systolic blood pressure (SBP)≥130mmHg/diastolic blood
pressure (DBP)≥85mmHg according to the IDF cut point for pre-hypertension or taking
blood pressure medication.(16)
Overweight and Abdominal Obesity—Height was measured without shoes to the
nearest 0.2 cm using a portable SECA stadiometer, and weight was measured without shoes
and in light clothing to the nearest 0.1 kg on a calibrated beam scale. Overweight was
defined using the recommended Asian BMI cut point of ≥23 kg/m2, with non-overweight
<23 kg/m2.(17) We also conducted comparative sensitivity analyses using the WHO
BMI≥25 kg/m2 cut point(18) (Supplemental Tables 4 and 5, Figure 2). Abdominal obesity
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twas classified using waist circumference, which was measured with a SECA tape measure
midway between the between the lower rib margin and the iliac crest. The IDF recommends
sex and ethnic-specific waist circumference cut points, thus the Asian cut point for
abdominal obesity for adults (waist circumference: men ≥90 cm; women ≥80 cm) was used.
(13) Abdominal obesity is associated with cardiometabolic risk, independent of BMI,(19)
particularly in individuals with normal BMI.(20, 21)
Metabolically Healthy and Overweight Categories—Cardiometabolic risk is defined
as having elevated values of one or more of the following five risk factors: inflammation
(hsCRP≥3 mg/L), pre-hypertension or hypertension (SBP/DBP≥130/85 mmHg), high
triglycerides (triglycerides: ≥150 mg/dL), low HDL-C: (male: <40mg/dL; female<50 mg/
dL), and pre-diabetes or diabetes (HbA1c≥5.7%). Patterns of risk associated with
overweight were used to define the following four categories: “metabolically healthy, non-
overweight” (BMI< 23 kg/m2, no risk factors); “metabolically healthy, overweight” (BMI≥
23 kg/m2, no risk factors); “metabolically at risk, non-overweight” (BMI< 23 kg/m2, ≥ 1
risk factor); and “metabolically at risk, overweight” (BMI≥ 23 kg/m2, ≥ 1 risk factor).
Inflammation was considered part of the cardiometabolic risk profile since in developing
countries, high rates of obesity occur alongside high rates of infectious disease and
malnutrition, resulting in dual burden of obesity-related and pathogen-related
inflammation(22) and future cardiovascular disease.(23) Abdominal obesity was not
considered in the definitions of these phenotypes due to its covariation with BMI and
conceptual interest in the association of abdominal obesity with these phenotypes.
Control variables—Age was recorded as the respondent’s age on the date of exam,
ranging from 18 to 98 years and categorized into the following categories: 18–30, 30–40,
40–50, 50–60, 60–70, and >70 years. Number of cigarettes per day were reported and
categorized as currently smoking one or more cigarettes per day. Alcohol was reported as
number of alcoholic beverages consumed per week across a variety of beverage types,
categorized according to consumption of ≥ 1 servings of alcohol per day. Physical activity
was reported using a detailed 7-day physical activity recall instrument and leisure activities
assigned Metabolic Equivalent (MET) values using the Compendium of Physical activity,
(24) which has been used in international contexts, including China.(25) MET values were
multiplied by the time spent in each activity and categorized according to ≥27 METs per
week, equivalent to ≥1 hour per week of moderate-intensity, such as brisk walking.
Urbanicity was defined using a multidimensional 12 component urbanization index
capturing community-level physical, social, cultural, and economic environments and
represents the heterogeneity otherwise missed in an urban/rural measure based only on
population density.(26) Tertiles of the 100 value index represent low, medium, and high
urbanicity. Household assets and household income were used to derive income; tertiles
represent low, medium, and high income.(27)
Statistical Analyses
We conducted statistical analyses using Stata (Release 11.0, Stata Corporation, College
Station, TX). In descriptive analyses, markers are compared across overweight status
(percentages for categorical variables, means for continuous variables). A series of models
were used to examine overweight (BMI≥23 kg/m2) and cardiometabolic risk patterning (≥1
of the following risk factors: inflammation, pre-hypertension or hypertension, high
triglycerides, low HDL-C, pre-diabetes or diabetes) and assesses the independent and
interactive effects of overweight and abdominal obesity (waist circumference: men ≥90 cm;
women ≥80 cm). First, multinomial regression models predicting risk of falling into one of
four categories: 1) “metabolically healthy, normal weight”, 2) “metabolically healthy,
overweight”, 3) “metabolically at risk, overweight,” and 4) “metabolically at risk, normal
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tweight”[referent], with abdominal obesity as the main exposure were used to test the
hypothesis that abdominal obesity would differentially predict membership into one of the
four risk categories. Second, a series of five separate logistic regression models for each
outcome (inflammation, pre-hypertension or hypertension, high triglycerides, low HDL-C,
pre-diabetes or diabetes) were used sequentially to test the hypotheses that: 1) overweight
(first main exposure) differentially associates with each cardiometabolic risk factor, and 2)
abdominal obesity (second main exposure), controlling for overweight, confers differential
risk for each cardiometabolic marker. Third, five separate and sequential logistic regression
models for each outcome (inflammation, pre-hypertension or hypertension, high
triglycerides, low HDL-C, pre-diabetes or diabetes) with four main exposure variables: 1)
overweight with abdominal obesity; 2) overweight with no abdominal obesity; 3) non-
overweight with abdominal obesity; and 4) non-overweight with no abdominal obesity
[referent], were used to test the hypothesis that there is an interactive effect between
overweight and abdominal obesity, with overweight and abdominal obese individuals at
highest risk. All models were sex-stratified and included the following covariates: age,
smoking, alcohol consumption, physical activity, urbanicity, and income. While model
building suggested minimal change in effect of the main exposure with the addition of
smoking, alcohol consumption, physical activity, urbanicity, and income, these covariates
were retained on conceptual grounds. Two forms of sensitivity analyses were performed: (1)
using the BMI≥25 kg/m2 cut point rather than the more stringent Asian BMI≥23 kg/m2 cut
point, and (2) using impaired fasting glucose (≥100 mg/dL) as opposed to HbA1c (pre-
diabetes or diabetes) as the indicator of diabetes risk. Results from both sensitivity analyses
are shown in the Supplemental Materials.
RESULTS
While approximately half of the sample was overweight, 78% had elevated values of one or
more cardiometabolic risk factors (49% had more than two) (Table 1). The proportion with
pre-hypertension or hypertension (42.8%) and pre-diabetes or diabetes (38.1%) was
particularly high. Rates of isolated hypertension risk (9.9%) and pre-diabetes or diabetes
(7.7%) were roughly twice as high as isolated high triglycerides, low HDL-C, and
inflammation, which were around 4%. In addition, mean waist circumference of the
metabolically healthy non-overweight group were on average 16 cm less than that of the
metabolically at risk overweight group, 10 cm less than the metabolically healthy
overweight, and 3 cm less than the metabolically at risk non-overweight group.
All cardiometabolic risk factors were higher among the overweight (Table 2). The
proportion of overweight and non-overweight individuals with inflammation, pre-
hypertension or hypertension, and pre-diabetes or diabetes increased with age, whereas rates
of both high triglycerides and low HDL-C were highest in the early adult years for men and
HDL-C was relatively stable among women. Relative to the other risk factors, differences in
hypertension risk by overweight status were not as large. Mean continuous values for each
marker are shown in Supplemental Table 1.
A comparatively large proportion of the sample across all age groups was “metabolically at
risk normal weight”, notably 42% of the total sample aged 18–30 (Figure 1). There were
very few “metabolically healthy overweight” individuals and the proportion of the sample
considered metabolically healthy (regardless of overweight status) declined considerably
with age. Findings were similar across low, medium, and high urbanicity.
We used multinomial regression models to test the hypothesis that abdominal obesity
differentially predicted membership into one of the four categories of obesity with and
without metabolic risk (Table 3). The odds of being in the “metabolically at risk
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toverweight” compared to the metabolically healthy, non-overweight group was dramatically
elevated with abdominal obesity (men, Odds Ratio (OR): 39.06, 95% Confidence Interval
(CI): 23.47–65.00; women, OR: 22.26, CI: 17.49–28.33). Abdominal obesity was also
predictive of having high metabolic risk among both non-overweight and overweight
individuals.
We used cardiometabolic risk factor-specific logistic regression models to examine the
association between overweight and each risk factor, with and without control for abdominal
obesity (Set A, models 1 and 2). One set of models included overweight exposure only
(Table 4, Column 2), a second set of models included both overweight and abdominal
obesity as exposure variables (Table 4, Column 3). As expected, overweight independently
increased the risk of each cardiometabolic marker in men and women, with variation across
indicators. Independent of overweight status, abdominal obesity conferred risk for all
cardiometabolic indicators.
A third set of cardiometabolic risk factor-specific logistic regression models was used to
examine the interactive association between overweight and abdominal obesity with each
risk factor (Set B models): 1) overweight with abdominal obesity, 2) overweight with no
abdominal obesity, and 3) non-overweight with abdominal obesity relative to 4) non-
overweight with no abdominal obesity. Overweight individuals with abdominal obesity were
at comparatively high cardiometabolic risk, with variation across pre-hypertension or
hypertension, pre-diabetes or diabetes, inflammation and dyslipidemia (Table 4, Column 6).
In the majority of cases, there was close to or above a threefold higher risk with the
combination of overweight and abdominal obesity relative to non-overweight and no
abdominal obesity.
Sensitivity Analysis Results
Results were remarkably similar when impaired fasting glucose (≥100 mg/dL) as opposed to
HbA1c (pre-diabetes or diabetes) was used as the indicator of diabetes risk (Supplemental
Tables 2 and 3, Supplemental Figure 1). Further, results were similar when overweight was
defined using BMI ≥25 kg/m2 cut point(18) (Supplemental Tables 4 and 5), but with a
considerably larger portion of the population considered “metabolically at risk non-
overweight” (Supplemental Figure 2). Relative to the BMI ≥23 kg/m2 cut point, using the
BMI ≥25 kg/m2 cut point suggests that abdominal obesity has the same (albeit stronger)
positive association with the metabolically at risk overweight.
DISCUSSION
Over three-quarters of this national Chinese sample had elevated levels of at least one
cardiometabolic risk factor. Even in young adults, only half were “metabolically healthy” at
18–30 years of age, but this decreased to 6% in the 60–70 year olds. Findings were similar
across low, medium, and high urbanicity, indicating high prevalence of metabolic
abnormalities even in the rural Chinese population, according to the IDF criteria for
metabolic risk. Just over 5% of the overweight adults had no risk factors. Among the non-
overweight adults, 33.2% had at least one risk factor. Rates of isolated high triglycerides,
low HDL-C, and inflammation were relatively low. The predominant risk factor was
hypertension risk, which increased dramatically with age, underlying the decline with age in
the proportion of adults considered metabolically healthy. While we cannot rule out the fact
that the high rates of hypertension risk might be a result of the normal increase in blood
pressure with age, the high prevalence of metabolic abnormalities among the 18–30 year old
group, particularly in low HDL-C and high triglycerides, is notable. Our findings highlight
the importance of screening in the general population, given the large portion of non-
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toverweight individuals with cardiometabolic risk. This should be at the forefront in China’s
efforts to prevent and control non-communicable diseases.
Previous research suggests that hypertension risk is particularly high in China and is found
at low BMI levels in Asians relative to other subpopulations.(5, 28, 29) A recent paper on
diabetes in China documented high diabetes prevalence,(30) although that sample does not
represent poor, less urbanized areas, as well as the CHNS. While HDL-C tends to be
relatively low in Asians,(31) rates of low HDL-C were not extraordinary in these Chinese
adults. Inflammation, a risk factor for type 2 diabetes and cardiovascular disease,(32–34) is
associated with insulin resistance and cardiometabolic risk in the absence of obesity.(35)
The observed findings suggest that inflammation increases with age across all adults, which
is common in developing countries where high rates of obesity occur alongside high rates of
infectious disease and malnutrition, resulting in dual burden of obesity-related and
pathogen-related inflammation.(22) Elevated hsCRP is a strong independent risk factor for
future cardiovascular events, regardless of the underlying condition.(15) For example, risk
may be present even if the underlying etiology relates to periodontal disease, which is an
independent risk factor for coronary heart disease.(36) Despite the sex difference in
abdominal obesity (largely due to the lower threshold for abdominal obesity in women (80
cm) versus men (90 cm), inflammation rates were similar. The combined association
between overweight and abdominal obesity with cardiometabolic risk factors suggests a
multiplicative effect on cardiometabolic risk, with risk that is magnified in overweight
individuals, even after controlling for smoking, alcohol consumption, total physical activity,
urbanicity, and income.
Most cardiometabolic screening is aimed at individuals above a given threshold of body
mass, despite the fact that elevated cardiometabolic risk is common in the general
population.(37) The observed high risk among non-overweight Chinese, and the increase in
risk with age, implies that screening for cardiometabolic risk should occur across all adults,
regardless of weight status. Further, the high prevalence of pre-hypertension and
hypertension, pre-diabetes or diabetes, high triglycerides, low HDL-C, and inflammation
risk even below the BMI 23 kg/m2 threshold supports a lower BMI cut point for the Chinese
population.(4, 17)
China has had a history of undernutrition followed by the most rapid increase in obesity and
related diseases worldwide, with differential rates across rural and urban areas.(2, 38) In the
last decade, changes in diet and activity in China have occurred more rapidly than
previously recorded for any country,(2) including increased intake of edible oil, fried foods,
animal source foods and snacking, as well as declining occupational, domestic, and travel
activity expenditure and increasing TV time.(25, 39) The observed findings fit with the trend
towards less healthier lifestyles, and indicate elevated cardiometabolic risk even in the rural
areas of China.
There are a few limitations to this analysis. This cross-sectional analysis does not examine
trends in risk or determinants of cardiometabolic risk. The main objective of this study was
to determine the prevalence of “metabolically healthy overweight” and “metabolically at
risk non-overweight” in Chinese adults and to examine patterns of risk by age and gender.
As such, the analytic strategy was designed to adjust for key covariates, rather than
undertaking causal modeling of these relationships. The use of conventional, anthropometric
and cardiometabolic cut points do not capture differences in cardiometabolic risk that exist
on the continuum of BMI and waist circumference. Likewise, cut points do not capture the
complex process of cardiometabolic risk However, cut points are needed for clinical
guidance and there is rationale for use of Asian-specific BMI cut points based on higher risk
at lower BMI.(4, 17, 40) Finally, BMI does not discriminate between lean and adipose tissue
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tand waist circumference is an indicator of both the subcutaneous and visceral adipose tissue
compartments,(41) thus we cannot distinguish the two.
In summary, findings suggest a high prevalence of cardiometabolic risk in China that
increases with age. The majority of the sample is considered metabolically at risk, with
similar patterns of risk across urbanicity. Rates of risk increase dramatically with age and
with overweight and abdominal obesity. The combined association between overweight and
abdominal obesity with cardiometabolic risk factors, even after controlling for smoking,
alcohol consumption, total physical activity, urbanicity, and income, suggest extraordinary
burden of future cardiovascular disease with population increases in weight and abdominal
obesity – a major clinical concern. Screening for cardiometabolic-related outcomes
dependent upon overweight will likely miss a large portion of the Chinese at-risk population
and has implications for other Asian populations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Concurrent Overweighta and Cardiometabolic Riskb, Total Population and Across
Urbanicity
aOverweight defined using the BMI≥23 kg/m2 cutpoint(17)
bCardiometabolic Risk, defined as one or more of the following risk factors: dysglycemia
(HbA1c≥5.7%) inflammation (hsCRP ≥3 mg/L), pre-hypertension/hypertension (SBP/
DBP≥130/85 mmHg), high triglycerides (≥150 mg/dL), low high-density lipoprotein
cholesterol (<40 mg/dL, men; <50 mg/dL, women).
NOTE: MH NW = Metabolically Healthy, Normal Weight
MH OW = Metabolically Healthy, Overweight
MAR NW = Metabolically at Risk, Normal Weight
MAR OW =Metabolically at Risk, Overweight
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